Therefore, the in vivo synergistic effect of high-dose BCG induced the downregulation of peripheral CD11b+/Gr-1+ MDSCs that was observed in the bladder cancer orthotopic model. This evidence concerns the gene ITGAM and urinary bladder carcinoma.